About Candesant
Candesant is a company based in San Francisco (United States) founded in 2016 by Niquette Hunt. Candesant has raised $44.49 million across 2 funding rounds from investors including KCK MedTech, Polaris Partners and Astia. The company has 3 employees as of December 31, 2021. Candesant operates in a competitive market with competitors including Sebacia, PhotoSonix Medical, Luma Therapeutics, Nano Ceuticals and Tiny Fat Eraser, among others.
- Headquarter San Francisco, United States
- Employees 3 as on 31 Dec, 2021
- Founders Niquette Hunt
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Candesant Biomedical, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$44.49 M (USD)
in 2 rounds
-
Latest Funding Round
$35.36 M (USD), Series B
Jun 06, 2023
-
Investors
KCK MedTech
& 3 more
-
Employee Count
3
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Candesant
Unlock access to complete
Funding Insights of Candesant
Candesant has successfully raised a total of $44.49M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $35.36 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Candesant
Candesant has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include KCK MedTech, Polaris Partners and Astia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
US focused venture capital firm
|
Locked | Locked | Locked | |
|
Women-led startups are funded through stage-agnostic investments and angel networks.
|
Locked | Locked | Locked |
Investor details for Candesant
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Candesant
Investment portfolio details for Candesant
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Candesant
Detailed financials for Candesant
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Candesant Comparisons
Peer comparison for Candesant
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Candesant
Candesant operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sebacia, PhotoSonix Medical, Luma Therapeutics, Nano Ceuticals and Tiny Fat Eraser, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Develops topical microparticle therapies for dermatological conditions.
|
|
| Locked | Locked | Locked |
Combination Ultrasound & Phototherapy transducer for antibiotic resistant skin infections
|
|
| Locked | Locked | Locked |
Offers coal tar and light combination therapy for effective psoriasis treatment.
|
|
| Locked | Locked | Locked |
Nanoparticle-based products for cosmetics and health sectors are developed.
|
|
| Locked | Locked | Locked |
Sells devices for fat reduction, body shaping, and skin firming online.
|
Detailed competitors of Candesant
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Candesant
Complete news archive for Candesant
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Candesant
Candesant was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Candesant is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Niquette Hunt is the current CEO of Candesant. They have also founded this company.
Candesant is a funded company, having raised a total of $44.49M across 2 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Candesant is 3.
Candesant Biomedical was founded in 2016 in San Francisco, United States, and operates in the biomedical sector. A proprietary non-invasive device, CDX-101, is offered for treating hyperhidrosis by targeting and inactivating overactive sweat glands. The device is applied under the arms like a patch, where alkali metals interact with water to generate energy that reduces sweating and inhibits bacterial growth.
Candesant's top competitors include PhotoSonix Medical, Nano Ceuticals and Sebacia.
Candesant has 4 investors. Key investors include KCK MedTech, Polaris Partners, Astia, and Correlation Ventures.